The efficacy and safety of flexible dosage ranges of risperidone versus placebo in the treatment of manic episodes associated with bipolar I disorder.
Phase of Trial: Phase III
Latest Information Update: 19 Oct 2006
At a glance
- Drugs Risperidone (Primary)
- Indications Bipolar I disorders
- Focus Registrational; Therapeutic Use
- Sponsors Janssen Research & Development
- 19 Oct 2006 New trial record.